Cargando…
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. th...
Autores principales: | Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Chezar-Azerrad, Chava, Hashim, Hayder, Ben-Dor, Itsik, Satler, Lowell F., Mintz, Gary S., Waksman, Ron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241397/ https://www.ncbi.nlm.nih.gov/pubmed/32471712 http://dx.doi.org/10.1016/j.carrev.2020.05.027 |
Ejemplares similares
-
CLINICAL OUTCOMES AND PREDICTORS OF COVID-19 PATIENTS WITH TROPONIN ELEVATION AND CONCOMITANT RENAL DYSFUNCTION
por: Case, Brian, et al.
Publicado: (2021) -
The Impact of COVID-19 Patients With Troponin Elevation on Renal Impairment and Clinical Outcome
por: Case, Brian C., et al.
Publicado: (2021) -
Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020) -
CLINICAL IMPACT AND PREDICTORS OF TROPONIN ELEVATION IN PATIENTS WITH COVID-19
por: Case, Brian, et al.
Publicado: (2021) -
Comparison of Outcomes in Patients With COVID-19 and Thrombosis Versus Those Without Thrombosis
por: Case, Brian C., et al.
Publicado: (2021)